FindTrial
Sign In

Study of heart rhythm changes and their relation to disease severity in patients with liver cirrhosis

QT prolongation and relation to severity in cirrhotics - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103108
Enrollment
200
Registered
2026-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Sankalp Gyani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Liver cirrhosis

Exclusion criteria

Exclusion criteria: Cirrhotic with known cardiomyopathy Patients with baseline electrolyte abnormalities Patients on drugs that affect QT interval

Design outcomes

Primary

MeasureTime frame
To look for the direct relationship between QT prolongation and severity in cirrhosisTimepoint: At baseline, 4 weeks and 8 weeks—

Secondary

MeasureTime frame
To use this information in risk stratification & management of cirrhotic patientsTimepoint: At baseline, 4 weeks & 8 weeks—

Countries

India

Contacts

Public ContactSankalp Gyani

Kasturba Medical College, Manipal, MAHE

drshiran@gmail.com8861920517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026